PharmChem Price To Sales vs. Book Value Per Share

PCHM Stock  USD 3.05  0.00  0.00%   
Taking into consideration PharmChem's profitability measurements, PharmChem may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess PharmChem's ability to earn profits and add value for shareholders.
For PharmChem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PharmChem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PharmChem utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PharmChem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PharmChem over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Please note, there is a significant difference between PharmChem's value and its price as these two are different measures arrived at by different means. Investors typically determine if PharmChem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PharmChem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PharmChem Book Value Per Share vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining PharmChem's current stock value. Our valuation model uses many indicators to compare PharmChem value to that of its competitors to determine the firm's financial worth.
PharmChem is rated below average in price to sales category among its peers. It also is rated below average in book value per share category among its peers creating about  2,172  of Book Value Per Share per Price To Sales. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PharmChem's earnings, one of the primary drivers of an investment's value.

PharmChem Book Value Per Share vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

PharmChem

P/S

 = 

MV Per Share

Revenue Per Share

 = 
0.0006 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

PharmChem

Book Value per Share

 = 

Common Equity

Average Shares

 = 
1.30 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.

PharmChem Book Value Per Share Comparison

PharmChem is currently under evaluation in book value per share category among its peers.

PharmChem Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in PharmChem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PharmChem will eventually generate negative long term returns. The profitability progress is the general direction of PharmChem's change in net profit over the period of time. It can combine multiple indicators of PharmChem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States.

PharmChem Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on PharmChem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PharmChem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PharmChem's important profitability drivers and their relationship over time.

Use PharmChem in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PharmChem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will appreciate offsetting losses from the drop in the long position's value.

PharmChem Pair Trading

PharmChem Pair Trading Analysis

The ability to find closely correlated positions to PharmChem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PharmChem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PharmChem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PharmChem to buy it.
The correlation of PharmChem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PharmChem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PharmChem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PharmChem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your PharmChem position

In addition to having PharmChem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Outsourcing Thematic Idea Now

Outsourcing
Outsourcing Theme
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in PharmChem Pink Sheet

To fully project PharmChem's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of PharmChem at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include PharmChem's income statement, its balance sheet, and the statement of cash flows.
Potential PharmChem investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although PharmChem investors may work on each financial statement separately, they are all related. The changes in PharmChem's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on PharmChem's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.